Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody by Davide Corti, John Misasi, Sabue Mulangu, Daphne A.

Slides:



Advertisements
Similar presentations
Nasty viruses and Institutional Review Boards. WHO: 50 million cases/yr.
Advertisements

Immune Strategies for HIV Prevention
This week: Protection from Pathogens. esophagus stomach Taking in food and oxygen exposes us to pathogens.
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail by James Pettitt, Larry Zeitlin, Do H.
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia by Michael Kalos, Bruce.
Structural Bioinformatics Section Vaccine Research Center/NIAID/NIH
Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies by Xiangguo Qiu, Jonathan Audet, Gary Wong, Stephane Pillet,
Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates by Gary Wong, Jason S. Richardson, Stéphane.
Are Bats Spreading Ebola Across Sub-Saharan Africa? by Gretchen Vogel Science Volume 344(6180): April 11, 2014 Published by AAAS.
Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase by Mayra García, Arik Cooper, Wei Shi, William Bornmann, Ricardo Carrion,
Food Security: The Challenge of Feeding 9 Billion People by H. Charles J. Godfray, John R. Beddington, Ian R. Crute, Lawrence Haddad, David Lawrence, James.
First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip by Robert Farra, Norman F. Sheppard, Laura McCabe, Robert M. Neer, James M. Anderson,
Response to Comment on “Modafinil Shifts Human Locus Coeruleus to Low-Tonic, High-Phasic Activity During Functional MRI” by Michael J. Minzenberg, Andrew.
Economic reasoning and artificial intelligence by David C. Parkes, and Michael P. Wellman Science Volume 349(6245): July 17, 2015 Published by AAAS.
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection by Kartik Chandran, Nancy J. Sullivan, Ute Felbor, Sean P. Whelan, and.
A smartphone dongle for diagnosis of infectious diseases at the point of care by Tassaneewan Laksanasopin, Tiffany W. Guo, Samiksha Nayak, Archana A. Sridhara,
CD34+ Cord Blood Cell-Transplanted Rag2−/− γc−/− Mice as a Model for Epstein-Barr Virus Infection Mario Cocco, Cristiana Bellan, Roxane Tussiwand, Davide.
The Recent Increase in Atlantic Hurricane Activity: Causes and Implications by Stanley B. Goldenberg, Christopher W. Landsea, Alberto M. Mestas-Nuñez,
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial,
Current Problems in the Management of Marine Fisheries by J. R. Beddington, D. J. Agnew, and C. W. Clark Science Volume 316(5832): June 22, 2007.
Hierarchical MoS 2 tubular structures internally wired by carbon nanotubes as a highly stable anode material for lithium-ion batteries by Yu Ming Chen,
A global quantification of “normal” sleep schedules using smartphone data by Olivia J. Walch, Amy Cochran, and Daniel B. Forger Science Volume 2(5):e
Molecular Evolution and Ebola
Oncolytic Viruses: Therapeutics With an Identity Crisis
Movie 1 Top and side view volume renderings of filopodia in a HeLa cell expressing mEmerald-Lifeact.The high speed of the dithered mode of lattice light-sheet.
by Karin Stettler, Martina Beltramello, Diego A
Cities are the Future by Nicholas S. Wigginton, Julia Fahrenkamp-Uppenbrink, Brad Wible, and David Malakoff Science Volume 352(6288): May 20, 2016.
Delays hinder Ebola genomics
by Yue Shen, Wang Zhang, Shu-Lei Chou, and Shi-Xue Dou
New Hope in the Search for Ebola Virus Treatments
Ending hide and seek at sea
Competition binding assays.
(A) NK cell cytotoxicity assays against K562, H9, and Raji target cell lines in the presence (black) and absence (white) of an anti-NKp30 antibody, clone.
by Chuan-Chao Wang, Qi-Liang Ding, Huan Tao, and Hui Li
by Angela L. Rasmussen, Atsushi Okumura, Martin T
HIV Immunology Goes Out On a Limb
Structure of V3-containing HIV-1 gp120 core
Phenotypic and molecular characterization of multidrug-resistant Salmonella enterica serovar Hadar in Greece, from 2007 to 2010  T. Papadopoulos, E. Petridou,
Forest health in a changing world
Fig. 1. Working principle of the plasmon sensor chip (NPS) for tEVs.
by Michael J. Mina, C. Jessica E. Metcalf, Rik L. de Swart, A. D. M. E
Models of education in medicine, public health, and engineering
by Zachary A. Bornholdt, Hannah L. Turner, Charles D
Student-Directed Discovery of the Plant Microbiome and Its Products
The Antisense Transcriptomes of Human Cells
by Zachary A. Bornholdt, Hannah L. Turner, Charles D
by Davide Corti, John Misasi, Sabue Mulangu, Daphne A
Characterization of an Avian Influenza A (H5N1) Virus Isolated from a Child with a Fatal Respiratory Illness by Kanta Subbarao, Alexander Klimov, Jacqueline.
Ebola Virus, Neutrophils, and Antibody Specificity
Volume 12, Issue 12, Pages (September 2015)
Volume 393, Issue 10174, Pages (March 2019)
Fig. 7. Inhibitory mechanisms of C12G6.
Rapid development of a DNA vaccine for Zika virus
Fig. 1. In vitro binding and neutralization activities of C12G6.
Volume 21, Issue 10, Pages (December 2017)
by Jelena Stajic, Richard Stone, Gilbert Chin, and Brad Wible
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
by Hohjai Lee, Yuan-Chung Cheng, and Graham R. Fleming
Congratulations! Now Get to Work
Ebolavirus’s Foibles Cell
by Karin Stettler, Martina Beltramello, Diego A
by Katelyn M. Gostic, Monique Ambrose, Michael Worobey, and James O
Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China by Y. Guan, B. J. Zheng, Y. Q. He, X. L. Liu,
Bispecific Antibodies Against HIV
Broadening Horizons: New Antibodies Against Influenza
Cure of HIV infection: Is the long wait over?
Ebola from Bedside to Bench
Feverish Quest for Ebola Immunotherapy: Straight or Cocktail?
by John Misasi, Morgan S. A
From Vaccines to Memory and Back
Presentation transcript:

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody by Davide Corti, John Misasi, Sabue Mulangu, Daphne A. Stanley, Masaru Kanekiyo, Suzanne Wollen, Aurélie Ploquin, Nicole A. Doria-Rose, Ryan P. Staupe, Michael Bailey, Wei Shi, Misook Choe, Hadar Marcus, Emily A. Thompson, Alberto Cagigi, Chiara Silacci, Blanca Fernandez-Rodriguez, Laurent Perez, Federica Sallusto, Fabrizia Vanzetta, Gloria Agatic, Elisabetta Cameroni, Neville Kisalu, Ingelise Gordon, Julie E. Ledgerwood, John R. Mascola, Barney S. Graham, Jean-Jacques Muyembe-Tamfun, John C. Trefry, Antonio Lanzavecchia, and Nancy J. Sullivan Science Volume ():aad5224 February 25, 2016 Published by AAAS

Fig. 1 Isolation of antigen-specific monoclonal antibodies from Ebola virus disease survivor. Davide Corti et al. Science 2016;science.aad5224 Published by AAAS

Fig. 2 Characterization of purified EBOV GP monoclonal antibodies. Davide Corti et al. Science 2016;science.aad5224 Published by AAAS

Fig. 3 Binding regions and effector function. Davide Corti et al. Science 2016;science.aad5224 Published by AAAS

Fig. 4 Passive transfer of antibody cocktail. Davide Corti et al. Science 2016;science.aad5224 Published by AAAS